Effects of Short-term Adaptation to Ketogenic Diet on Endurance Trained Athletes
Glycogen Depletion, Nutritional Ketosis, and Exercise Fatigue: Novel Assessment Methods and Psychobiological Mechanisms
1 other identifier
interventional
24
1 country
1
Brief Summary
Skeletal muscle glycogen is a major endogenous carbohydrate store and an important substrate for ATP resynthesis during exercise. Its utilization increases with exercise intensity and duration, and low muscle glycogen availability has long been associated with impaired endurance exercise capacity. Beyond its role as a metabolic substrate, glycogen availability may influence excitation-contraction coupling and Ca²⁺ handling, providing multiple mechanisms through which carbohydrate availability can affect contractile function and fatigue. Ketogenic diets (KD), characterized by severe carbohydrate restriction (\<5% of energy intake), induce a profound redistribution of exercise metabolism. Reduced carbohydrate availability markedly increases fat oxidation while decreasing reliance on carbohydrate and muscle glycogen during exercise. This adaptation has frequently been interpreted as a glycogen-sparing mechanism that could extend endogenous carbohydrate availability during prolonged exercise. However, reduced glycogen utilization does not necessarily imply glycogen preservation, particularly when exercise begins with substantially lower muscle glycogen stores. Direct evidence quantifying muscle glycogen before and after a standardized exercise bout during ketogenic adaptation remains limited. The marked shift toward lipid oxidation may also have consequences for exercise energetics. Fat oxidation provides less ATP per unit of oxygen consumed than carbohydrate oxidation, thereby increasing the oxygen requirement for a given rate of oxidative ATP resynthesis. This may become particularly relevant as exercise intensity and ATP demand increase, when carbohydrate-derived energy provision becomes progressively more important. Thus, ketogenic adaptation may reduce glycogen utilization while simultaneously increasing the oxygen cost of exercise and limiting the capacity to sustain higher exercise intensities. Nutritional ketosis may additionally influence exercise responses beyond skeletal muscle metabolism. KD markedly increases circulating β-hydroxybutyrate (βHB), which can be utilized as an oxidative substrate by peripheral tissues and crosses the blood-brain barrier, contributing to cerebral oxidative metabolism. Whether increased ketone availability modifies the cerebral response to exercise, and whether this relates to perceptual or exercise responses during carbohydrate restriction, remains unclear. Accordingly, the specific aims are:
- 1.To determine the effects of 10 days of ketogenic adaptation on skeletal muscle glycogen availability and utilization during standardized prolonged exercise. It is hypothesized that KD reduces resting muscle glycogen and attenuates exercise-induced glycogen utilization without preserving post-exercise glycogen availability.
- 2.To determine the effects of ketogenic adaptation on substrate oxidation, exercise energetics, and exercise capacity. It is hypothesized that the shift toward greater lipid oxidation increases the oxygen cost of standardized submaximal exercise and impairs both prolonged exercise tolerance and subsequent high-intensity endurance capacity.
- 3.To explore circulating substrate, perceptual, and cerebral responses to exercise during nutritional ketosis. Glucose, lactate, and βHB responses, together with prefrontal cortical oxygenation assessed by functional near-infrared spectroscopy (fNIRS), are examined to determine whether the pronounced peripheral metabolic adaptations are accompanied by detectable alterations in cerebral hemodynamic or perceptual responses.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Nov 2024
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2025
CompletedFirst Submitted
Initial submission to the registry
September 18, 2026
CompletedFirst Posted
Study publicly available on registry
September 24, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
September 30, 2026
CompletedSeptember 29, 2026
September 1, 2025
1.2 years
September 18, 2026
September 24, 2026
Conditions
Outcome Measures
Primary Outcomes (3)
Skeletal muscle glycogen
Resting Skeletal muscle glycogen and skeletal muscle utilization during exercise
10 days
Endurance performance
Overall exercise tolerance will be quantified as total exercise duration (min), defined as the combined duration of the 2-h submaximal exercise bout and the subsequent TTE. Subsequent high-intensity endurance capacity will be quantified separately as TTE duration (min) .
10 days
Pre-frontal cortex hemodynamics and perceived fatigability during endurance exercise
Functional near-infrared spectroscopy (fNIRS) was used to evaluate prefrontal cortex hemodynamics during exercise + questionnaire ( ROF, Feeiling scale)
10 days
Study Arms (2)
KETOGENIC DIET (KD)
EXPERIMENTALwill follow ketogenic diet during the intervention
CONTROL DIET
ACTIVE COMPARATORwill follow control diet (55% carbohydrate) during the intervention
Interventions
Eligibility Criteria
You may qualify if:
- Male
- Age 18-40 yr,
- BMI: 18-25 kg/m\^2,
- At least two years of endurance training experience
- a cycling volume of at least 150 km·week
- habitual consumption of a carbohydrate-based diet (\>50% of total daily energy intake from carbohydrates)
You may not qualify if:
- Chronic diseases
- Acute inflammatory states
- Psychiatric disorders
- Recent (within 3 months) treatment with anabolic steroids or systemic corticosteroids
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Padovalead
- University of Bolognacollaborator
Study Sites (1)
Department of Biomedical Sciences, University of Padus
Padova, Italy, 10034, Italy
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 18, 2026
First Posted
September 24, 2026
Study Start
November 1, 2024
Primary Completion
December 31, 2025
Study Completion
September 30, 2026
Last Updated
September 29, 2026
Record last verified: 2025-09